NTRK1 and hereditary sensory and autonomic neuropathy type 4: CIPA is thought to result from loss-of-function mutation defects in TRKA, which encodes the neurotrophic tyrosine kinase receptor type 1 (NTRK1 or TRKA), a high-affinity receptor for nerve growth factor (NGF) [2].